Health
Study: Targeting glycoprotein could improve response to cancer immunotherapy – News-Medical.Net
It was an unexpected discovery that started with an analysis of more than 1,000 genes. The question: why game-changing cancer immunotherapy treatments work for…
It was an unexpected discovery that started with an analysis of more than 1,000 genes. The question: why game-changing cancer immunotherapy treatments work for only a fraction of patients.
The analysis shone a light on one that popped up repeatedly in patients and mouse models that did not respond to immune checkpoint therapy: stanniocalcin-1, a glycoprotein whose role in both tumors and immunology is largely unknown.
By following the trail from this surprising thread, a University of Michigan Rogel…
-
Noosa News13 hours agoTwo teenagers and two adults rushed to hospital in life-threatening conditions after shocking Lawnton house fire
-
Noosa News14 hours agoA secret scheme and plans to expel former leaders — here’s what we’ve heard from Queensland’s inquiry into the CFMEU
-
Noosa News13 hours agoFatal traffic crash, Noosa – Sunshine Coast
-
Business14 hours agoTop brokers name 3 ASX shares to buy next week 23 November 2025